217 related articles for article (PubMed ID: 25148825)
21. Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract.
Int J Toxicol; 2004; 23 Suppl 2():49-54. PubMed ID: 15513824
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
23. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
[TBL] [Abstract][Full Text] [Related]
25. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
26. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
[TBL] [Abstract][Full Text] [Related]
27. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
28. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Stefanska B; Salamé P; Bednarek A; Fabianowska-Majewska K
Br J Nutr; 2012 Mar; 107(6):781-90. PubMed ID: 21801466
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
32. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
33. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
Zhang YY; Tian WP; Mei M
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation of LINE-1 repeat elements and global loss of DNA hydroxymethylation in vapers and smokers.
Caliri AW; Caceres A; Tommasi S; Besaratinia A
Epigenetics; 2020 Aug; 15(8):816-829. PubMed ID: 31996072
[TBL] [Abstract][Full Text] [Related]
35. Tet1-dependent epigenetic modification of BDNF expression in dorsal horn neurons mediates neuropathic pain in rats.
Hsieh MC; Lai CY; Ho YC; Wang HH; Cheng JK; Chau YP; Peng HY
Sci Rep; 2016 Nov; 6():37411. PubMed ID: 27857218
[TBL] [Abstract][Full Text] [Related]
36. Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators.
Deb M; Sengupta D; Kar S; Rath SK; Parbin S; Shilpi A; Roy S; Das G; Patra SK
Tumour Biol; 2014 Dec; 35(12):12031-47. PubMed ID: 25192721
[TBL] [Abstract][Full Text] [Related]
37. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
Fukagawa A; Ishii H; Miyazawa K; Saitoh M
Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
Zhou Q; Atadja P; Davidson NE
Cancer Biol Ther; 2007 Jan; 6(1):64-9. PubMed ID: 17172825
[TBL] [Abstract][Full Text] [Related]
39. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
[TBL] [Abstract][Full Text] [Related]
40. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]